Page 205 - Guida alle Vaccinazioni
P. 205

167. Smith KC, Orme J.M and Starke JF. Tuberculosis vaccines Vaccines 6^ edizione a cura di Plotkin SA,
Orestein WA, Offit PA. Edizioni Elselver 2012 (35) 789-811.

168. World Health Organization. Global Advisory Committee on Vaccine Safety,3–4 December 2009. WER
2010, 85, 29–36.

http://www.who.int/wer/2010/wer8505.pdf?ua=1

169. Levine M. Typhoid fever vaccines Vaccines 6^ edizione a cura di Plotkin SA, Orestein W A, Offit PA
Edizioni Elselver 2012 (36) 812-836.

170. Global advisory Committee on Vaccine Safety, Safety of varicella vaccine in immunocompromised
populations. WER 2013,88: 301–312.

http://www.who.int/wer/2013/wer8829.pdf?ua=1

171. Farquhar C, Wamalwa D, Selig S, et al. Immune responses to measles and tetanus vaccines among

Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active
antiretroviral therapy and revaccination. Pediatr Infect Dis J. 2009;28:295–299.

172. Aurpibul L, Puthanakit T, Sirisanthana T, et al. Response to measles, mumps, and rubella revaccination

in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clin Infect Dis.
2007;45:637–642.

173. Abzug MJ, Qin M, Levin MJ, et al. International Maternal Pediatric Adolescent AIDS Clinical Trials
Group P1024 and P1061s Protocol Teams. Immunogenicity, immunologic memory, and safety following
measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis.
2012;206:512–522.

174. Gershon AA, Takahashi M and Seward JF. Varicella vaccine Vaccines 6^ edizione a cura di Plotkin SA,
Orestein WA, Offit PA. Edizioni Elselver 2012 (37):837-869.

175. Esposito S, Prada E, Lelli M and al. Immunization of children with secondary immunodeficiency. Human
vaccines & immunotherapeutics. 2015 (1) 2564-70.

176. World Health Organization. Epatitis B vaccines: WHO position paper. WER 2017; 27:369-392.

http://apps.who.int/iris/bitstream/10665/255841/1/WER9227.pdf?ua=1

177. Ljungman P. Vaccination of immunocompromised hosts. Vaccines 6^ edizione a cura di Plotkin SA,
Orestein WA, Offit PA. Edizioni Elselver 2012; (63) 1243-1256.

178. Cesaro S, Giacchino M, Fioredda F et al. Review Article Guidelines on Vaccinations in Paediatric
Haematology and Oncology Patients. BioMed Research International Volume 2014 (2014): 1-10.

179. Hibberd PL. Immunizations in patients with cancer. updated: Maggio 2016

www.updated.com/contents/immunizations -in-patients-with-cancer/

https://www.uptodate.com/contents/immunizations-in-patients-with-cancer

180. Esposito S, Cecinati V, Brescia L et al. Vaccinations in children with cancer. Vaccine 2010 (28): 3278-
3284.

181. Van Damme P, John Ward J, Daniel Shouval D et al. Hepatitis B vaccines virus vaccines. Vaccines 6^
edizione a cura di Plotkin SA, Orestein WA, Offit PA. Edizioni Elselver 2012: (15) 205-234.

182. World Health Organization. Rotavirus vaccines WHO position paper. WER 2013, 88, 49–64.

http://www.who.int/wer/2013/wer8805.pdf?ua=1

183. Cortese MM, and Parashar UD. Prevention of Rotavirus Gastroenteritis Among Infants and Children
Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2009;58/ ( RR-2):
1-26.

https://www.cdc.gov/mmwr/pdf/rr/rr5802.pdf

                                                                                                              205
   200   201   202   203   204   205   206   207   208   209   210